Cite
HARVARD Citation
Berbée, M. et al. (n.d.). PO-1793: BioXmark liquid fiducials to enable radiotherapy tumor boosting in rectal cancer feasibility trial. Radiotherapy and oncology. pp. S1000-S1001. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Berbée, M. et al. (n.d.). PO-1793: BioXmark liquid fiducials to enable radiotherapy tumor boosting in rectal cancer feasibility trial. Radiotherapy and oncology. pp. S1000-S1001. [Online].